Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Kelso, Joel K ^a   Halder, Nilimesh ^a   Postma, Maarten J ^b   Milne, George J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Antiviral medication; Case fatality ratio; Economic analysis; Pandemic influenza; Pandemic severity; Social distancing

Indexed keywords

ANTIVIRUS AGENT;

ARTICLE; AUSTRALIA; COMPUTER SIMULATION; COST OF ILLNESS; ECONOMICS; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VIRUS A H5N1; MORTALITY; PANDEMIC; SEVERITY OF ILLNESS INDEX; SOCIAL DISTANCE; STATISTICAL MODEL; STATISTICS;

ANTIVIRAL AGENTS; AUSTRALIA; COMPUTER SIMULATION; COST OF ILLNESS; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, ECONOMIC; MORTALITY; PANDEMICS; SEVERITY OF ILLNESS INDEX; SOCIAL DISTANCE;

MLCS; MLOWN;

EID: 84874731413     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-211     Document Type: Article

References (70)

1. Critical Care Services and 2009 H1N1 influenza in Australia and New Zealand. ANZIC Influenza Investigators, N Engl J Med 2009 2009 361 1925 1934
2. Europe's initial experience with pandemic (H1N1) 2009-mitigation and delaying policies and practices. Nicoll A, Coulombier D, Euro Surveill 2009 14 29 ii=19279
3. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, Pebody RG, Yardley IE, Br Med J 2009 339 5213 10.1136/bmj.b5213
4. Analysis of the effectiveness of interventions used during the 2009 H1N1 influenza pandemic. Halder N, Kelso J, Milne G, BMC Publ Health 2010 10 168 10.1186/1471-2458-10-168
5. Developing guidelines for school closure interventions to be used during a future influenza pandemic. Halder N, Kelso J, Milne G, BMC Infect Dis 2010 10 1 221 10.1186/1471-2334-10-221 20659348
6. Mitigation strategies for pandemic influenza in the United States. Germann TC, Kadau K, Longini IM Jr, Macken CA, PNAS 2006 103 15 5935 5941 10.1073/pnas.0601266103 16585506
7. Targeted social distancing design for pandemic influenza. Glass RJ, Glass LM, Beyeler WE, Min HJ, Emerg Infect Dis 2006 12 11 1671 1681 10.3201/eid1211.060255 17283616 (Pubitemid 44674242)
8. Reducing the impact of the next influenza pandemic using household-based public health interventions. Wu JT, Riley S, Fraser C, Leung GM, PLoS Med 2006 3 9 1532 1540 (Pubitemid 44455264)
9. Effective, robust design of community mitigation for pandemic influenza: a systematic examination of proposed US guidance. Davey VJ, Glass RJ, Min HJ, Beyeler WE, Glass LM, PLoS One 2008 3 7 2606 10.1371/journal.pone.0002606 18596963
10. A small community model for the transmission of infectious diseases: comparison of school closure as an intervention in individual-based models of an influenza pandemic. Milne GJ, Kelso JK, Kelly HA, Huband ST, McVernon J, PLoS One 2008 3 12 4005 10.1371/journal.pone.0004005 19104659
11. Simulation suggests that rapid activation of social distancing can arrest epidemic development due to a novel strain of influenza. Kelso JK, Milne GJ, Kelly HA, BMC Publ Health 2009 9 117 10.1186/1471-2458-9-117
12. School closure is currently the main strategy to mitigate influenza A(H1N1)v: a modelling study. Sypsa V, Hatzakis A, Euro Surveill 2009 14 24 pi=19240
13. Modelling mitigation strategies for pandemic (H1N1) 2009. Gojovic MZ, Sander B, Fisman D, Krahn MD, Bauch CT, Can Med Assoc J 2009 181 10 673 680 10.1503/cmaj.091641
14. Nature Outlook: Influenza. Phillip Campbell, Nature 2011 480 7376 Suppl 1 S15 22158293
15. Airborne transmission of influenza A/H5N1 virus between ferrets. Herfst S, Schrauwen EJA, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Science 2012 336 6088 1534 1541 10.1126/science.1213362 22723413
16. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Nature 2012 486 7403 420 428 22722205
17. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Russell CA, Fonville JM, Brown AEX, Burke DF, Smith DL, James SL, Herfst S, van Boheemen S, Linster M, Schrauwen EJ, Science 2012 336 6088 1541 1547 10.1126/science.1222526 22723414
18. Statistics of influenza morbidity with special reference to certain factors in case incidence and case fatality. Frost W, Public Heath Report 1920 35 584 597 10.2307/4575511
19. Emerging infections: pandemic influenza. Glezen WP, Epidemiol Rev 1996 18 1 64 76 10.1093/oxfordjournals.epirev.a017917 8877331 (Pubitemid 26303555)
20. The 2004 Australian Census: http://www.abs.gov.au
21. A Bayesian MCMC approach to study transmission of influenza: application to household longitudinal data. Cauchemez S, Carrat F, Viboud C, Valleron AJ, Boelle PY, Stat Med 2004 23 22 3469 3487 10.1002/sim.1912 15505892 (Pubitemid 39467864)
22. Estimating the impact of school closure on influenza transmission from Sentinel data. Cauchemez S, Valleron AJ, Boelle PY, Flahault A, Ferguson NM, Nature 2008 452 7188 750 754 10.1038/nature06732 18401408 (Pubitemid 351521077)
23. Strategies for mitigating an influenza pandemic. Ferguson NM, Cummings DAT, Fraser C, Cajka JC, Cooley PC, Burke DS, Nature 2006 442 448 452 10.1038/nature04795 16642006 (Pubitemid 44264793)
24. Papoulis A, Probability, random variables and stochastic processes New York: McGraw-Hill 2 1984
25. Tecumseh study of illness XIII. Influenza infection and disease, 1976-1981. Monto A, Koopman J, Longini IMJ, Am J Epidemiol 1985 121 6 811 822 4014174 (Pubitemid 15028257)
26. Pandemic potential of a strain of influenza A (H1N1): early findings. Fraser C, Christl DA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, Griffin J, Baggaley RF, Jenkins HE, Lyons EJ, Science 2009 324 1557 1561 10.1126/science.1176062 19433588
27. Pandemic (H1N1) 2009 influenza community transmission was established in one Australian state when the virus was first identified in North America. Kelly H, Mercer G, Fielding J, Dowse G, Glass K, Carcione D, Grant KA, Effler PV, Lester RA, Gravenor MB, PLoS One 2010 5 6 11341 10.1371/journal.pone.0011341 20596536
28. Estimating the reproduction number of the novel influenza A virus (H1N1) in a Southern Hemisphere setting: preliminary estimate in New Zealand. Nishiura H, Wilson N, Baker M, J N Z Med Assoc 2009 122 1299 73 77
29. Epidemiological and transmissibility analysis of influenza A (H1N1) v in a southern hemisphere setting: Peru. Munayco C, Gomez J, Laguna-Torres V, Arrasco J, Kochel T, Fiestas V, Garcia J, Perez J, Torres I, Condori F, Euro Surveill 2009 14 32 ii=19299
30. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron A-J, Am J Epidemiol 2008 167 7 775 785 10.1093/aje/kwm375 18230677 (Pubitemid 351451744)
31. Early transmission characteristics of influenza A (H1N1) v in Australia: Victorian state, 16 May-3 June 2009. McBryde E, Bergeri I, van Gemert C, Rotty J, Headley E, Simpson K, Lester R, Hellard M, Fielding J, Euro Surveill 2009 14 42 ii=19363
32. Serial intervals and the temporal distribution of secondary infections within households of 2009 pandemic influenza A (H1N1): implications for influenza control recommendations. Donnelly CA, Finelli L, Cauchemez S, Olsen SJ, Doshi S, Jackson ML, Kennedy ED, Kamimoto L, Marchbanks TL, Morgan OW, Clin Infect Dis 2011 52 suppl 1 123 21342883
33. Influenzavirus infections in Seattle families, 1975-1979. Fox JP, Hall CE, Cooney MK, Foy HM, Am J Epidemiol 1982 116 2 212 227 7114033
34. Containing pandemic influenza at the source. Longini IM Jr, Nizam A, Xu S, Ungchusak K, Hanshaoworakul W, Cummings DAT, Halloran ME, Science 2005 309 1083 1088 10.1126/science.1115717 16079251 (Pubitemid 41134467)
35. Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups. Yang Y, Longini IM Jr, Halloran ME, Appl Statist 2006 55 317 330 (Pubitemid 43536589)
36. Temporal factors in school closure policy for mitigating the spread of influenza. Zhang T, Fu X, Kwoh CK, Xiao G, Wong L, Ma S, Soh H, Lee GKK, Hung T, Lees M, J Public Health Policy 2011 32 2 180 197 10.1057/jphp.2011.1 21326332
37. The impact of case diagnosis coverage and diagnosis delays on the effectiveness of antiviral strategies in mitigating pandemic influenza A/H1N1 2009. Kelso JK, Halder N, Milne GJ, PLoS One 2010 5 11 13797 10.1371/journal.pone.0013797 21072188
38. Containing pandemic influenza with antiviral agents. Longini I, Halloran M, Nizam A, Yang Y, Am J Epidemiol 2004 159 7 623 633 10.1093/aje/kwh092 15033640 (Pubitemid 38405377)
39. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. Hayden FG, Belshe R, Villanueva C, Lanno R, Hughes C, Small I, Dutkowski R, Ward P, Carr J, J Infect Dis 2004 189 3 440 449 10.1086/381128 14745701 (Pubitemid 38210580)
40. Neuraminidase inhibitors for influenza. Moscona A, N Engl J Med 2005 353 13 1363 1373 10.1056/NEJMra050740 16192481 (Pubitemid 41362704)
41. Simulating school closure strategies to mitigate an influenza epidemic. Lee BY, Brown ST, Cooley P, Potter MA, Wheaton WD, Voorhees RE, Stebbins S, Grefenstette JJ, Zimmer SM, Zimmerman R, J Public Health Manag Pract 2010 16 3 252 20035236
42. Interim pre-pandemic planning guidance: community strategy for pandemic influenza mitigation in the United States: http://www.flu.gov/planning- preparedness/community/community-mitigation.pdf
43. Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies. Newall AT, Wood JG, Oudin N, MacIntyre CR, Emerg Infect Dis 2010 16 2 224 230 10.3201/eid1602.090571 20113551
44. U.S. Bureau of Labor Statistics: http://www.bls.gov
45. Health outcomes and costs of community mitigation strategies for an influenza pandemic in the United States. Perlroth DJ, Glass RJ, Davey VJ, Cannon D, Garber AM, Owens DK, Clin Infect Dis 2009 50 165 174
46. Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. Sander B, Nizam A, Garrison LP Jr, Postma MJ, Halloran EM, Longini IM Jr, Value Health 2009 12 2 226 233 10.1111/j.1524-4733.2008.00437.x 18671770
47. Direct medical cost of influenza-related hospitalizations in children. Keren R, Zaoutis TE, Saddlemire S, Luan XQ, Coffin SE, Pediatrics 2006 118 1321 e1327 10.1542/peds.2006-0598 17079533 (Pubitemid 46393636)
48. Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir. Reddy D, J Antimicrob Chemother 2010 65 Suppl 2 i35 ii40 20215134
49. World Health Organization, Making choices in health: WHO guide to cost-effectiveness analysis Geneva: World Health Organization 2003
50. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. Presanis AM, De Angelis D, Hagy A, Reed C, Riley S, Cooper BS, Finella L, Biedrzyki P, Lipsitch M, The New York City Swine Flu Investiation Team, PLoS Med 2009 6 12 1000207 10.1371/journal.pmed.1000207 19997612
51. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, Bandaranayake D, Breiman RF, Brooks WA, Buchy P, Lancet Infect Dis 2009 12 9 687 695
52. Cost-effective strategies for mitigating a future influenza pandemic with H1N1 2009 characteristics. Halder N, Kelso J, Milne G, PLoS One 2011 6 7 22087 10.1371/journal.pone.0022087 21760957
53. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. Baguelin M, Hoek AJV, Jit M, Flasche S, White PJ, Edmunds WJ, Vaccine 2010 28 12 2370 2384 10.1016/j.vaccine.2010.01.002 20096762
54. USA Historical Consumer Price Index: http://rateinflation.com/consumer- price-index/usa-historical-cpi.php
55. Economics of neuraminidase inhibitor stockpiling for pandemic influenza, Singapore. Lee VJ, Phua KH, Chen MI, Chow A, Ma S, Goh KT, Leo YS, Emerg Infect Dis 2006 12 1 95 102 16494724 (Pubitemid 43143543)
56. Economic analysis of pandemic influenza vaccination strategies in Singapore. Lee VJ, Tok MY, Chow VT, Phua KH, Ooi EE, Tambyah PA, Chen MI, PLoS One 2009 4 9 7108 10.1371/journal.pone.0007108 19771173
57. Reactive strategies for containing developing outbreaks of pandemic influenza. Andradottir S, Chiu W, Goldsman D, Lee ML, Tsui KL, Sander B, Fisman DN, Nizam A, BMC Publ Health 2011 11 Suppl 1 1 10.1186/1471-2458-11-S1-S1
58. Measures against transmission of pandemic H1N1 influenza in Japan in 2009: simulation model. Yasuda H, Suzuki K, Euro Surveill 2009 14 44 pi=19385
59. WHO, Report of the Review Committee on the Functioning of the International Health Regulations (2005) in relation to Pancemic (H1N1) 2009 Geneva: World Health Organization 2011
60. An influenza simulation model for immunization studies. Elveback LR, Fox JP, Ackerman E, Langworthy A, Boyd M, Gatewood L, Am J Epidemiol 1976 103 2 152 165 814808
61. Individual-based Computational Modeling of Smallpox Epidemic Control Strategies. Burke DS, Epstein JM, Cummings DA, Parker JI, Cline KC, Singa RM, Chakravarty S, Acad Emerg Med 2006 13 11 1142 1149 10.1111/j.1553-2712.2006. tb01638.x 17085740 (Pubitemid 44636270)
62. Modeling targeted layered containment of an influenza pandemic in the United States. Halloran ME, Ferguson NM, Eubank S, Longini IM, Cummings DAT, Lewis B, Xu S, Fraser C, Vullikanti A, Germann TC, PNAS 2008 105 12 4639 10.1073/pnas.0706849105 18332436 (Pubitemid 351753799)
63. Mitigation measures for pandemic influenza in Italy: an individual based model considering different scenarios. Ciofi degli Atti ML, Merler S, Rizzo C, Ajelli M, Massari M, Manfredi P, Furlanello C, Tomba GS, Iannelli M, PLoS One 2008 3 3 1 11
64. The role of population heterogeneity and human mobility in the spread of pandemic influenza. Merler S, Ajelli M, Proc Royal Soc B: Biological Sciences 2010 277 1681 557 565 10.1098/rspb.2009.1605
65. Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania. Brown ST, Tai JHY, Bailey RR, Cooley PC, Wheaton WD, Potter MA, Voorhees RE, LeJeune M, Grefenstette JJ, Burke DS, BMC Publ Health 2011 11 1 353 10.1186/1471-2458-11- 353
66. The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment. Smith RD, Keogh-Brown MR, Barnett T, Tait J, Br Med J 2009 339 4571 10.1136/bmj.b4571
67. Globalization and Disease: The Case of SARS. Lee J-W, McKibbin WJ, Asian Economic Papers 2004 3 1 113 131 10.1162/1535351041747932
68. McKibbin W, Sidorenko A, Global macroeconomic consequences of pandemic influenza Sydney Australia: Lowy Institute for International Policy 2006 79
69. The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Bootsma MCJ, Ferguson NM, PNAS 2007 104 7588 7593 10.1073/pnas.0611071104 17416677 (Pubitemid 47185950)
70. Quantifying social distancing arising from pandemic influenza. Caley P, Philp DJ, McCracken K, J R Soc Interface 2007 6 631 639 (Pubitemid 351589745)